NCT00563732View on ClinicalTrials.gov

Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Alzheimer Disease
Interventions
DRUG

Lecozotan

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00563732 - Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin | Biotech Hunter | Biotech Hunter